Esophageal Adenocarcinoma Clinical Trials in Nijmegen
2 recruitingNijmegen, Netherlands
Showing 1–2 of 2 trials
Recruiting
Phase 2
Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus)
Esophageal AdenocarcinomaGastric Adenocarcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)25 enrolled8 locationsNCT05177133
Recruiting
Not Applicable
Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Adenocarcinoma
Barrett EsophagusSubmucosal Esophageal AdenocarcinomaHigh-risk Mucosal Esophageal Adenocarcinoma
Amsterdam UMC225 enrolled20 locationsNCT03222635